CLSI H51-A-2002

$48.10

Assays of von Willebrand Factor Antigen and Ristocetin Cofactor Activity

Published By	Publication Date	Number of Pages
CLSI	2002-09-01	43

Guaranteed Safe Checkout

Category: CLSI

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

Description

This guideline describes: appropriate test specimens, reagents and materials, methods of platelet agglutination and ELISA, preparation of reference curves, determination of reference intervals, quality control procedures, result interpretation, and sources of error for assays of von Willebrand factor antigen and ristocetin cofactor activity. A brief description of von Willebrand disease and its various subtypes is included, as well as a list of references to more comprehensive reviews of this commonly inherited and rarely acquired bleeding disorder.

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.

Additional information

Published Code	CLSI
Published By	Clinical and Laboratory Standards Institute
Publication Date	2002-09-01
Pages Count	43
Language	English
Descriptors	Factor VII, Laurell electroimmunoassay, ristocetin cofactor activity (R:CoF), von Willebrand disease (vWD), von Willebrand factor (vWF), von Willebrand factor antigen (vWFAg). von Willebrand factor multimers
Edition	1
File Size	512.0 KB
ISBN	1562384732

Preview PDF


PDF Format	Searchable	Printable	Preview Now

CLSI H51-A-2002

Related products